M.-M.N.); Tel.: +8625-8327-1080 (M.-M.N.) Figure S1 . Pharmacophore mapping of 9 peptides on the model. Pharmacophore features are color-coded: Green, two hydrophobic feature (F1 and F8: Hyd); cyan, three anionic and hydrogen bond acceptor features (F2-F4: Ani&Acc); blue, one hydrogen bond acceptor feature (F5: Acc); pink, one hydrogen bond donor and acceptor feature (F7: Don&Acc); orange, two aromatic features (F6 and F9: Aro).
. Pharmacophore mapping of 9 peptides on the model. Pharmacophore features are color-coded: Green, two hydrophobic feature (F1 and F8: Hyd); cyan, three anionic and hydrogen bond acceptor features (F2-F4: Ani&Acc); blue, one hydrogen bond acceptor feature (F5: Acc); pink, one hydrogen bond donor and acceptor feature (F7: Don&Acc); orange, two aromatic features (F6 and F9: Aro). Figure S2 . Key interactions of the 3,4-dichlorophenylalanine involved in stabilizing peptide 5 in the hydrophobic pocket of PLK1-PBD (PDB ID: 3Q1I). The peptide 5 is shown in yellow stick form; the hydrophobic pocket of PLK1-PBD is colored by a white line. NA, no significant inhibition at 1 μM inhibitor. All measurements were performed in triplicates and the IC 50 values represent the mean ± SD of three data sets. Table S3 . Sequences of 15 active peptides.
Peptides
Sequence a
